The New York Yankees are betting big on their bullpen's transformation, but here's where it gets controversial: can a retooled group of unproven arms and young prospects truly replace the star power they've lost? With just days left in the offseason, the Yankees' bullpen moves have been more about subtraction than addition, leaving fans and analysts alike scratching their heads. Two former closers, Devin Williams and Luke Weaver, are now headed to Queens, and several relievers have been nontendered, raising questions about how the team plans to cover those critical high-leverage innings.
But here’s the part most people miss: the Yankees believe they laid the groundwork for this bullpen makeover last summer, acquiring David Bednar, Camilo Doval, and Jake Bird—all under contract beyond 2025. They’ve also re-signed key players like Ryan Yarbrough and Paul Blackburn, added Tim Hill, and picked up Cade Winquest in the Rule 5 draft. On Wednesday, they acquired hard-throwing righty Angel Chivilli from the Rockies, a move that could pay dividends if his potential is harnessed. Is this enough to fill the void, or are the Yankees gambling too heavily on unproven talent?
General manager Brian Cashman remains optimistic, stating, ‘As we enter spring training, we’re a different bullpen than last year. We have young pups pushing up the ladder, a Rule 5 pick, and new additions like Chivilli. It’s a work in progress with a lot of quality choices.’ Yet, the reliance on prospects like Brent Headrick and Yerry De los Santos, along with the volatile nature of relievers, adds an element of risk. Even Bednar, now a key piece, was demoted to Triple-A by the Pirates in the same season he thrived as the Yankees’ closer.
Here’s the million-dollar question: Can the Yankees afford to sit out the free agent relief market, trusting their pitching department to develop these arms into reliable late-inning options? While they’ve reserved funds for Cody Bellinger, their recent success with impact relievers has come through trades, not free agency. Cashman insists they’ll continue evaluating options, but for now, they’re banking on internal growth.
Another wrinkle? The projected 2026 bullpen lacks flexibility. Only a handful of players, including Bird, Chivilli, and Headrick, have minor league options remaining, and the Yankees must keep Winquest on the big league roster all season to retain him. For a team that frequently shuffles its bullpen, this could prove challenging.
And let’s not forget the rotation. If Carlos Rodón, Gerrit Cole, and Clarke Schmidt return to full health, some relief could come from their side. But until then, the Yankees are placing immense faith in their pitching department to get Bird back on track, transition Blackburn to relieving, and unlock Chivilli’s potential.
So, what do you think? Are the Yankees setting themselves up for success, or are they one injury away from a bullpen crisis? Let us know in the comments—this is one debate that’s sure to spark differing opinions.
